Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Raises Price Target to $100

Benzinga Newsdesk www.benzinga.com Positive 91.5%

Neg 0% Neu 0% Pos 91.5%

Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $93 to $100.